Predictive Oncology Inc
POAI
查看详细走势图
5.950USD
0.000
收盘 12/24, 13:00（美东）报价延迟15分钟
4.56M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
0.00%
5天
0.00%
1月
-4.80%
6月
-54.92%
今年开始到现在
-51.63%
1年
-46.83%
查看详细走势图
TradingKey Predictive Oncology Inc股票评分
单位: USD 更新时间: 2025-12-11操作建议
Predictive Oncology Inc当前公司基本面数据相对谨慎，增长潜力较大。当前估值合理，在生物技术与医疗研究行业排名229/405位。机构持股占比低，近一月多位分析师给出公司评级为。最高目标价3.00。中期看，股价处于下降通道。近一个月，市场表现较差，但技术面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Predictive Oncology Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
3.000
目标均价
+251.62%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Predictive Oncology Inc亮点
亮点风险
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
业绩增长期
公司处于发展阶段，最新年度总收入1.62M美元
估值高估
公司最新PE估值-0.04，处于3年历史高位
机构减仓
最新机构持股7.39K股，环比减少77.87%
先锋集团持仓
明星投资者先锋集团持仓，最新持仓市值0.00
Predictive Oncology Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Predictive Oncology Inc简介
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
公司代码POAI
公司Predictive Oncology Inc
CEOVennare (Raymond F)
网址https://predictive-oncology.com/
常见问题
Predictive Oncology Inc(POAI)的当前股价是多少？
Predictive Oncology Inc(POAI)的当前股价是 5.950。
Predictive Oncology Inc的股票代码是什么？
Predictive Oncology Inc的股票代码是POAI。
Predictive Oncology Inc股票的52周最高点是多少？
Predictive Oncology Inc股票的52周最高点是45.900。
Predictive Oncology Inc股票的52周最低点是多少？
Predictive Oncology Inc股票的52周最低点是3.880。
Predictive Oncology Inc的市值是多少？
Predictive Oncology Inc的市值是4.56M。
Predictive Oncology Inc的净利润是多少？
Predictive Oncology Inc的净利润为-12.66M。
现在Predictive Oncology Inc(POAI)的股票是买入、持有还是卖出？
根据分析师评级，Predictive Oncology Inc(POAI)的总体评级为--，目标价格为3.000。
Predictive Oncology Inc(POAI)股票的每股收益（EPS TTM）是多少
Predictive Oncology Inc(POAI)股票的每股收益（EPS TTM）是-139.762。
相关品种
